https://scholars.lib.ntu.edu.tw/handle/123456789/413480
Title: | Inhibition of the Interleukin-36 Pathway for the Treatment of Generalized Pustular Psoriasis | Authors: | TSEN-FANG TSAI Choon S.-E. Marrakchi S. David Burden A. Morita A. Turki H. Hall D.B. Shear M. Baum P. Padula S.J. Thoma C. |
Issue Date: | 7-Mar-2019 | Publisher: | MASSACHUSETTS MEDICAL SOC | Journal Volume: | 380 | Journal Issue: | 10 | Start page/Pages: | 981 | Source: | The New England journal of medicine | URI: | https://scholars.lib.ntu.edu.tw/handle/123456789/413480 | ISSN: | 0028-4793 | DOI: | https://api.elsevier.com/content/abstract/scopus_id/85062722357 10.1056/NEJMc1811317 |
SDG/Keyword: | bi 655130; cytokine; cytokine receptor antagonist; interleukin 36; monoclonal antibody; unclassified drug; IL36RN protein, human; interleukin derivative; interleukin receptor; interleukin-36 receptor, human; drug efficacy; gene; gene mutation; generalized pustular psoriasis; generalized pustular psoriasis; human; IL36RN gene; Letter; priority journal; proof of concept; pustular psoriasis; antagonists and inhibitors; clinical trial; female; genetics; intravenous drug administration; male; metabolism; mutation; phase 1 clinical trial; psoriasis; severity of illness index; Administration, Intravenous; Female; Humans; Interleukins; Male; Mutation; Psoriasis; Receptors, Interleukin; Severity of Illness Index |
Appears in Collections: | 醫學系 |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.